Appeal No. 2005-0548 Application No. 09/839,164 Thus, even if we assume, arguendo, that representative claim 30 is limited to use of the pharmaceutical composition in humans, we would find the appellants’ argument to be inconsistent with the evidence of record. Accordingly, in view of the foregoing, the decision of the examiner is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 CFR § 1.136(a)(1)(iv). AFFIRMED JOAN ELLIS ) Administrative Patent Judge ) ) ) ) BOARD OF PATENT ) DONALD E. ADAMS ) APPEALS AND Administrative Patent Judge ) ) INTERFERENCES ) ) ) ERIC GRIMES ) Administrative Patent Judge ) JE/dpv 9Page: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007